FDA Inspection
Celerion IncCelerion Inc – FDA Inspection, Dec 8, 2017
Record Details
This FDA Inspection record concerns Celerion Inc, with an inspection on December 8, 2017, issued by the Kansas City District Office, covering human drugs.
- People
- Mohsen Rajabi Abhari (Issuing Officer)
- Yiyue C. Zhang (Issuing Officer)
View Company Profile
ID · e0923fac-b7e0-4bcb-a80b-4589df3df0e2
Inspection Facts
- Inspection number
- 1040283
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Celerion Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2025 | Not classified | Kansas City District Office | |
| November 21, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 11, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 24, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Celerion Inc
- FDA Inspection 1261246 - 2025-01-17
- FDA Inspection 1114326 - 2019-11-21
- FDA Inspection 1080997 - 2019-01-11
- FDA Inspection 734863 - 2011-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.